HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium-Reference-Cited by-同舟云学术

HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium

Published:2017-07-25 Issue:21 Volume:123 Page:4099-4105
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Pillai Rathi N.¹,Behera Madhusmita¹,Berry Lynne D.²,Rossi Mike R.³,Kris Mark G.⁴,Johnson Bruce E.⁵,Bunn Paul A.⁶,Ramalingam Suresh S.¹^ORCID,Khuri Fadlo R.¹^ORCID

Affiliation:

1. Department of Hematology and Medical Oncology; Winship Cancer Institute, Emory University; Atlanta Georgia

2. Vanderbilt Center for Quantitative Sciences; Vanderbilt-Ingram Cancer Center; Nashville Tennessee

3. Division of Cancer Biology; Department of Radiation Oncology, Emory University; Atlanta Georgia

4. Thoracic Oncology Service; Memorial Sloan Kettering Cancer Center; New York New York

5. Clinical Research; Dana-Farber Cancer Institute; Boston Massachusetts

6. Division of Medical Oncology; University of Colorado Cancer Center; Aurora Colorado

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference46 articles.

1. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol.,2001

2. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells;Fiore;Science.,1987

3. Insights from transgenic mouse models of ERBB2-induced breast cancer;Ursini-Siegel;Nat Rev Cancer.,2007

4. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science.,1989

5. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science.,1987

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein Expression, Amplification, and Mutation of HER2 Gene in Canine Primary Pulmonary Adenocarcinomas: Preliminary Results;Animals;2024-09-10

2. Quantitative Measurement of HER2 Expression in Non–Small Cell Lung Cancer With a High-Sensitivity Assay;Modern Pathology;2024-09

3. Prevalence and treatment of human epidermal growth factor receptor 2-altered non-small cell lung cancer: a retrospective analysis and systematic literature review;ecancermedicalscience;2024-08-01

4. Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis;Journal of Clinical Medicine;2024-07-31

5. Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non–Small Cell Lung Cancer: Single-Institution Experience;Cancer Research and Treatment;2024-07-15